Headache, particularly at initiation Mild anxiety or restlessness with some compounds Nasal irritation (intranasal administration) Sleep disturbance if dosed too close to bedtime Rare: Mood changes or emotional lability Dihexa (PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a potent hepatocyte growth factor (HGF) receptor agonist originally developed at Washington State University
Contaminated or degraded peptides pose risks that properly manufactured BPC-157 does not
Treatment The injection is typically administered into the deltoid (shoulder), vastus lateralis (thigh), or ventrogluteal (side of the hip) muscle
The reta + cag combination covers more pathways on paper, but it has no trial data of its own
By improving brain-body signaling, Dihexa may support: This is critical for maintaining healthy weight, energy levels, and hormonal balance as we age
discontinuation of oral contraceptives, although this has not been shown to result in regression of the tumor